NT-401

About Nano Pharmasolutions

Nano PharmaSolutions is a private, clinical-stage biotech leveraging its proprietary NanoTransformer® platform to reformulate drugs with poor solubility. The company's lead program, NT-301, is in Phase 1 trials and represents its strategic pivot towards CNS disorders via its Nano-CNS® nasal powder delivery platform. With a key manufacturing partnership with Mikart and a pipeline targeting Parkinson's disease and other neurological conditions, NPS is positioning itself in the high-value nanomedicine and CNS drug delivery space. The company appears to be pre-revenue, advancing its programs through partnerships and investor funding.

Therapeutic Areas

Other CNS Disorder Drugs